SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-045262
Filing Date
2019-12-04
Accepted
2019-12-04 17:13:20
Documents
3
Period of Report
2019-11-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - RIF ANNOUNCEMENT alna-8k_20191202.htm 8-K 38572
2 EX-99.1 alna-ex991_6.htm EX-99.1 22731
3 GRAPHIC gzsf0kl3rjvr000001.jpg GRAPHIC 5315
  Complete submission text file 0001564590-19-045262.txt   69980
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 191268823
SIC: 2836 Biological Products, (No Diagnostic Substances)